Molecular docking and network pharmacology study on active compounds of Cyprus rotundus for the treatment of diabetes mellitus
- PMID: 39498162
- PMCID: PMC11531456
- DOI: 10.1007/s40203-024-00273-6
Molecular docking and network pharmacology study on active compounds of Cyprus rotundus for the treatment of diabetes mellitus
Abstract
Background: Diabetes Mellitus (DM) is a complex metabolic disorder with increasing global prevalence, necessitating the exploration of novel therapeutic strategies. Cyprus rotundus, a medicinal plant with a long history of traditional use, has shown promising potential in managing DM.
Aim of the study: This study aims to elucidate the mechanism of action of active components of C. rotundus in managing DM using a combination of network pharmacology and molecular docking approaches.
Materials and methods: The active compounds of C. rotundus were identified through IMPPAT and CHEBI database mining. Subsequently, compound-target are taken from swiss target prediction and SEA. Collection of DM-related targets is done through DisGeNET and TTD database. After identifying both the targets, common targets were evaluated through venny 2.1.0. by constructing venn diagram. To elucidate the potential targets of these compounds, a protein-protein interaction network was constructed by utilizing STRING database. Through network analysis, we identified key targets and pathways involved in the pathogenesis of DM and targeted by the active components of C. rotundus. Furthermore, molecular docking was performed to explore the binding affinity and interactions between the active compounds and their target proteins.
Results: This, reveal that the 12 active components of C. rotundus exert their therapeutic effects on DM through multiple mechanisms, there are 141 common target genes between C. rotundus and DM. Enrichment of the KEGG pathway mainly involves in the AGE-RAGE signaling pathway in diabetic complications, Type II DM pathway. Top 10 genes were regulated by C. rotundus in DM, including MMP9, PTGS2, CASP3, CD4, EGFR, STAT3, PPARG, AKT1, NFKB1 and MAPK3. Molecular docking analysis further validates the strong binding affinity between the active compounds and their target proteins, providing insights into their mode of action at the molecular level.
Conclusions: This study provides a systematic understanding of the mechanism of action of C. rotundus in managing DM, offering a basis for further experimental validation and drug development.
Keywords: Cyprus rotundus; Diabetes mellitus; Molecular docking; Network pharmacology; Pathway.
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Conflict of interestThe authors declare no competing interests.
Similar articles
-
Elucidating the Mechanism of Xiaoqinglong Decoction in Chronic Urticaria Treatment: An Integrated Approach of Network Pharmacology, Bioinformatics Analysis, Molecular Docking, and Molecular Dynamics Simulations.Curr Comput Aided Drug Des. 2025 Jul 16. doi: 10.2174/0115734099391401250701045509. Online ahead of print. Curr Comput Aided Drug Des. 2025. PMID: 40676786
-
Systems Pharmacology-based Drug Discovery and Active Mechanism of Ganoderma lucidum Triterpenoids for Type 2 Diabetes Mellitus by Integrating Network Pharmacology and Molecular Docking.Curr Pharm Des. 2025;31(33):2666-2690. doi: 10.2174/0113816128365423250126035306. Curr Pharm Des. 2025. PMID: 39949090
-
Mechanism of action of Pulsatilla chinensis (Bunge) Regel compounds in hepatocellular carcinoma (HCC) treatment: An integrated analysis combining network pharmacology, molecular docking, molecular dynamics simulations and luciferase reporter gene assay.J Ethnopharmacol. 2025 Aug 29;352:120176. doi: 10.1016/j.jep.2025.120176. Epub 2025 Jun 19. J Ethnopharmacol. 2025. PMID: 40543694
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
References
-
- Ashtekar H, Dwivedi PSR, Aggarwal N, Fernandes Z, Varghese N (2023) In-silico validation of pyrazolone derivatives as the potent scaffold for modulating protein abnormalities associated with parkinson’s disease. International Journal of Drug Delivery Technology 13(1)
-
- Ayodele PF, Bamigbade A, Bamigbade OO, Adeniyi IA, Tachin ES, Seweje AJ, et al. (2023) Illustrated procedure to perform molecular docking using PyRx and biovia discovery studio visualizer: a case study of 10kt with atropine. Progress in Drug Discovery Biomedical Science 6(1)
-
- Borul SB, More SP (2022) Study of drug likeness properties substituted indazoles. International Journal of Creative Research Thoughts 10(2)
-
- Chowdhury HU, Adnan M, Oh KK, Cho DH (2021) Decrypting molecular mechanism insight of Phyllanthus emblica L. fruit in the treatment of type 2 diabetes mellitus by network pharmacology. Phytomedicine Plus 1(4)
-
- Ctri (2019) Ayurvedic Management on Type II Diabetes Mellitus. https://trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2019/02/017609
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
